Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital
The data presents 75 chronic myeloid leukemia patients diagnosed over a period 6 years i.e. from 2002 to 2008. The most common presentation was splenomegaly and 97% achieved complete hematological response at median duration of 4.3 weeks. The uniqueness of this study is follow-up with molecular resp...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2013-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=182;epage=185;aulast=Doval |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849699482569015296 |
|---|---|
| author | D C Doval Ullas Batra Sumit Goyal Ajay Sharma Saud Azam Rashmi Shirali |
| author_facet | D C Doval Ullas Batra Sumit Goyal Ajay Sharma Saud Azam Rashmi Shirali |
| author_sort | D C Doval |
| collection | DOAJ |
| description | The data presents 75 chronic myeloid leukemia patients diagnosed over a period 6 years i.e. from 2002 to 2008. The most common presentation was splenomegaly and 97% achieved complete hematological response at median duration of 4.3 weeks. The uniqueness of this study is follow-up with molecular response monitoring. Nearly, 30% patients achieved major molecular response (MMoR) by 12 months. 70% of patients achieved MMoR by median time of 60 months. Only 10% of the patient who achieved MMoR by 18 months had lost their responses subsequently. |
| format | Article |
| id | doaj-art-2fa479a8010b4c5fba8dc3522d4aa45b |
| institution | DOAJ |
| issn | 0971-5851 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-2fa479a8010b4c5fba8dc3522d4aa45b2025-08-20T03:18:34ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512013-01-0134318218510.4103/0971-5851.123725Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospitalD C DovalUllas BatraSumit GoyalAjay SharmaSaud AzamRashmi ShiraliThe data presents 75 chronic myeloid leukemia patients diagnosed over a period 6 years i.e. from 2002 to 2008. The most common presentation was splenomegaly and 97% achieved complete hematological response at median duration of 4.3 weeks. The uniqueness of this study is follow-up with molecular response monitoring. Nearly, 30% patients achieved major molecular response (MMoR) by 12 months. 70% of patients achieved MMoR by median time of 60 months. Only 10% of the patient who achieved MMoR by 18 months had lost their responses subsequently.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=182;epage=185;aulast=DovalChronic myeloid leukemiaDelhiImatinib |
| spellingShingle | D C Doval Ullas Batra Sumit Goyal Ajay Sharma Saud Azam Rashmi Shirali Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital Indian Journal of Medical and Paediatric Oncology Chronic myeloid leukemia Delhi Imatinib |
| title | Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital |
| title_full | Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital |
| title_fullStr | Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital |
| title_full_unstemmed | Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital |
| title_short | Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital |
| title_sort | chronic myeloid leukemia treatment with imatinib an experience from a private tertiary care hospital |
| topic | Chronic myeloid leukemia Delhi Imatinib |
| url | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=182;epage=185;aulast=Doval |
| work_keys_str_mv | AT dcdoval chronicmyeloidleukemiatreatmentwithimatinibanexperiencefromaprivatetertiarycarehospital AT ullasbatra chronicmyeloidleukemiatreatmentwithimatinibanexperiencefromaprivatetertiarycarehospital AT sumitgoyal chronicmyeloidleukemiatreatmentwithimatinibanexperiencefromaprivatetertiarycarehospital AT ajaysharma chronicmyeloidleukemiatreatmentwithimatinibanexperiencefromaprivatetertiarycarehospital AT saudazam chronicmyeloidleukemiatreatmentwithimatinibanexperiencefromaprivatetertiarycarehospital AT rashmishirali chronicmyeloidleukemiatreatmentwithimatinibanexperiencefromaprivatetertiarycarehospital |